Skip to main content
NIH funding notice RFA-MH-20-326

Dysregulation and Proximal Risk for Suicide (R21 Clinical Trial Optional)

Closed on February 13, 2020.

Posted
November 8, 2019
Close date
February 13, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $469,885 in first-year total cost, median $234,943.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-S (07)]2

Most frequent institutions

  1. FORDHAM UNIVERSITY1
  2. TEXAS TECH UNIVERSITY1
Competing awards under RFA-MH-20-326 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Dynamic Regulatory Processes in the Transition from Suicidal Ideation to Action: The Roles of Cognitive Control, Emotion-Related Impulsivity, and Sleep in the Context of Negative Affective Experiences1R21MH124794-01VICTOR, SARAH ELIZABETHTEXAS TECH UNIVERSITY, TX$236,997ZMH1
2021Sleep disturbance and inhibitory control as proximal predictors of suicidal ideation and behavior: A daily diary and actigraphy study of young adults1R21MH124902-01ANDOVER, MARGARET S.FORDHAM UNIVERSITY, NY$232,888ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-MH-20-326: Dysregulation and Proximal Risk for Suicide (R21 Clinical Trial Optional) | ScienceDex | ConductScience